T0	Participants 135 184	following adjuvant chemotherapy for breast cancer
T1	Participants 493 510	for breast cancer
T2	Participants 804 854	for chemotherapy-naïve patients with breast cancer
T3	Participants 1076 1081	to 8.
T4	Participants 1082 1234	Median age of the 94 women was 51 years (range 27-76): 79 received fluorouracil/epirubicin/cyclophosphamide and 15 received doxorubicin/cyclophosphamide